530 related articles for article (PubMed ID: 32445619)
1. Single-Cell RNA Sequencing of Tumor-Infiltrating NK Cells Reveals that Inhibition of Transcription Factor HIF-1α Unleashes NK Cell Activity.
Ni J; Wang X; Stojanovic A; Zhang Q; Wincher M; Bühler L; Arnold A; Correia MP; Winkler M; Koch PS; Sexl V; Höfer T; Cerwenka A
Immunity; 2020 Jun; 52(6):1075-1087.e8. PubMed ID: 32445619
[TBL] [Abstract][Full Text] [Related]
2. The HIF-1α hypoxia response in tumor-infiltrating T lymphocytes induces functional CD137 (4-1BB) for immunotherapy.
Palazón A; Martínez-Forero I; Teijeira A; Morales-Kastresana A; Alfaro C; Sanmamed MF; Perez-Gracia JL; Peñuelas I; Hervás-Stubbs S; Rouzaut A; de Landázuri MO; Jure-Kunkel M; Aragonés J; Melero I
Cancer Discov; 2012 Jul; 2(7):608-23. PubMed ID: 22719018
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducible factor-1 alpha expression is induced by IL-2 via the PI3K/mTOR pathway in hypoxic NK cells and supports effector functions in NKL cells and ex vivo expanded NK cells.
Cluff E; Magdaleno CC; Fernandez E; House T; Swaminathan S; Varadaraj A; Rajasekaran N
Cancer Immunol Immunother; 2022 Aug; 71(8):1989-2005. PubMed ID: 34999917
[TBL] [Abstract][Full Text] [Related]
4. Association of Germline Variants in Natural Killer Cells With Tumor Immune Microenvironment Subtypes, Tumor-Infiltrating Lymphocytes, Immunotherapy Response, Clinical Outcomes, and Cancer Risk.
Xu X; Li J; Zou J; Feng X; Zhang C; Zheng R; Duanmu W; Saha-Mandal A; Ming Z; Wang E
JAMA Netw Open; 2019 Sep; 2(9):e199292. PubMed ID: 31483464
[TBL] [Abstract][Full Text] [Related]
5. A Transcriptional Signature of PDGF-DD Activated Natural Killer Cells Predicts More Favorable Prognosis in Low-Grade Glioma.
Sun Y; Sedgwick AJ; Palarasah Y; Mangiola S; Barrow AD
Front Immunol; 2021; 12():668391. PubMed ID: 34539622
[TBL] [Abstract][Full Text] [Related]
6. Early activation and interferon-γ production of tumor-infiltrating mature CD27 high natural killer cells.
Hayakawa Y; Sato-Matsushita M; Takeda K; Iwakura Y; Tahara H; Irimura T
Cancer Sci; 2011 Nov; 102(11):1967-71. PubMed ID: 21781225
[TBL] [Abstract][Full Text] [Related]
7. Tumor microenvironmental conversion of natural killer cells into myeloid-derived suppressor cells.
Park YJ; Song B; Kim YS; Kim EK; Lee JM; Lee GE; Kim JO; Kim YJ; Chang WS; Kang CY
Cancer Res; 2013 Sep; 73(18):5669-81. PubMed ID: 23867469
[TBL] [Abstract][Full Text] [Related]
8. Phenotype and Function of Activated Natural Killer Cells From Patients With Prostate Cancer: Patient-Dependent Responses to Priming and IL-2 Activation.
Hood SP; Foulds GA; Imrie H; Reeder S; McArdle SEB; Khan M; Pockley AG
Front Immunol; 2018; 9():3169. PubMed ID: 30761160
[No Abstract] [Full Text] [Related]
9. A hypoxia-induced decrease of either MICA/B or Hsp70 on the membrane of tumor cells mediates immune escape from NK cells.
Schilling D; Tetzlaff F; Konrad S; Li W; Multhoff G
Cell Stress Chaperones; 2015 Jan; 20(1):139-47. PubMed ID: 25103413
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of Tumor-Infiltrating Natural Killer Cells in Solid Tumors: A Systematic Review and Meta-Analysis.
Zhang S; Liu W; Hu B; Wang P; Lv X; Chen S; Shao Z
Front Immunol; 2020; 11():1242. PubMed ID: 32714321
[No Abstract] [Full Text] [Related]
11. Downregulation of Hypoxia Inducible Factor-1α in Primary Human Natural Killer Cells Using Small Interfering RNA Delivery with ExPERT ATx by MaxCyte.
Velásquez SY; Baslar GE; Schulte J; Fuderer T; Lindner HA; Coulibaly A
Curr Protoc; 2024 Feb; 4(2):e987. PubMed ID: 38327104
[TBL] [Abstract][Full Text] [Related]
12. Functional and metabolic targeting of natural killer cells to solid tumors.
Wang J; Matosevic S
Cell Oncol (Dordr); 2020 Aug; 43(4):577-600. PubMed ID: 32488848
[TBL] [Abstract][Full Text] [Related]
13. HIF-1α induces immune escape of prostate cancer by regulating NCR1/NKp46 signaling through miR-224.
Chen CH; Li SX; Xiang LX; Mu HQ; Wang SB; Yu KY
Biochem Biophys Res Commun; 2018 Sep; 503(1):228-234. PubMed ID: 29885835
[TBL] [Abstract][Full Text] [Related]
14. Transfer learning between preclinical models and human tumors identifies a conserved NK cell activation signature in anti-CTLA-4 responsive tumors.
Davis-Marcisak EF; Fitzgerald AA; Kessler MD; Danilova L; Jaffee EM; Zaidi N; Weiner LM; Fertig EJ
Genome Med; 2021 Aug; 13(1):129. PubMed ID: 34376232
[TBL] [Abstract][Full Text] [Related]
15. Tumor-Associated Monocytes/Macrophages Impair NK-Cell Function via TGFβ1 in Human Gastric Cancer.
Peng LS; Zhang JY; Teng YS; Zhao YL; Wang TT; Mao FY; Lv YP; Cheng P; Li WH; Chen N; Duan M; Chen W; Guo G; Zou QM; Zhuang Y
Cancer Immunol Res; 2017 Mar; 5(3):248-256. PubMed ID: 28148545
[TBL] [Abstract][Full Text] [Related]
16. Targeting of CXCR3 improves anti-myeloma efficacy of adoptively transferred activated natural killer cells.
Bonanni V; Antonangeli F; Santoni A; Bernardini G
J Immunother Cancer; 2019 Nov; 7(1):290. PubMed ID: 31699153
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-15 Signaling in HIF-1α Regulation in Natural Killer Cells, Insights Through Mathematical Models.
Coulibaly A; Bettendorf A; Kostina E; Figueiredo AS; Velásquez SY; Bock HG; Thiel M; Lindner HA; Barbarossa MV
Front Immunol; 2019; 10():2401. PubMed ID: 31681292
[TBL] [Abstract][Full Text] [Related]
18. PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation.
Noman MZ; Desantis G; Janji B; Hasmim M; Karray S; Dessen P; Bronte V; Chouaib S
J Exp Med; 2014 May; 211(5):781-90. PubMed ID: 24778419
[TBL] [Abstract][Full Text] [Related]
19. Natural Killer Cell Recruitment and Activation Are Regulated by CD47 Expression in the Tumor Microenvironment.
Nath PR; Pal-Nath D; Mandal A; Cam MC; Schwartz AL; Roberts DD
Cancer Immunol Res; 2019 Sep; 7(9):1547-1561. PubMed ID: 31362997
[TBL] [Abstract][Full Text] [Related]
20. Deletion of the mRNA endonuclease Regnase-1 promotes NK cell anti-tumor activity via OCT2-dependent transcription of Ifng.
Sun X; Nagahama Y; Singh SK; Kozakai Y; Nabeshima H; Fukushima K; Tanaka H; Motooka D; Fukui E; Vivier E; Diez D; Akira S
Immunity; 2024 Jun; 57(6):1360-1377.e13. PubMed ID: 38821052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
